
PCR, Next Generation Sequencing, and Microarrays. We support clinics with any molecular diagnostics technology they encounter.
Our commitment to research and technology is relentless.

Assurance!
Our testing methods improve patient compliance and outcomes, supported by world-class customer service and practical analytics.

and ensuring satisfaction with our work.
test
Primary Immunodeficiency Disorders (PIDs)
We analyze cheek cells to detect genetic variants associated with primary immunodeficiency disorders (PIDs) to ensure proper diagnosis and treatment.
Comprehensive Cancer
Comprehensive Cancer
We use cheek cells to perform comprehensive hereditary cancer testing, identifying genetic predispositions to cancers like hereditary breast and ovarian cancer syndrome, Lynch syndrome, and Li-Fraumeni syndrome, enabling personalized risk assessments and tailored treatments.
PGX
PGX
We use cheek cells for pharmacogenetic (PGx) testing to determine how your genes affect your response to medications, helping healthcare providers choose the most effective and safe treatments tailored to your genetic profile.
BRCA
BRCA
We analyze cheek cells for changes in your BRCA1 and BRCA2 genes to assess cancer risk, helping you safeguard your health and prepare for a healthier future.
Microbiome
Microbiome
We use a stool sample to perform a comprehensive gut microbiome test, analyzing your gut flora to provide insights into your gut health and guide better dietary choices. For GI tract health concerns, consult a healthcare provider. Get a gut microbiome test at GDx lab to proactively improve your gut health.
Our Technologies
Our Technologies
GDxLab, founded by Genomics and Genetics experts, offers next-generation testing services using advanced molecular diagnostics like PCR, Next Generation Sequencing, and Microarrays to support precision medicine.